Advertisement

Topics

Emerald Health Pharmaceuticals Inc.: Emerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Huntington's Disease

03:09 EST 26 Feb 2018 | FinanzNachrichten

SAN DIEGO, CA / ACCESSWIRE / February 26, 2018 / Emerald Health Pharmaceuticals Inc. (EHP), which is developing medicines based on cannabinoid science, today announced that it has been granted Orph...

Original Article: Emerald Health Pharmaceuticals Inc.: Emerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Huntington's Disease

NEXT ARTICLE

More From BioPortfolio on "Emerald Health Pharmaceuticals Inc.: Emerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Huntington's Disease"

Advertisement
Quick Search
Advertisement
Advertisement